Related Experiment Videos
Invasive group A streptococcal infections in Florida
Zuber D Mulla1, Paul E Leaverton, Steven T Wiersma
1Department of Epidemiology and Biostatistics, University of South Florida, Tampa, FL, USA. zmulla@utep.edu
Southern Medical Journal
|October 23, 2003
Summary
This study found clindamycin treatment significantly reduces mortality in invasive Group A streptococcal (GAS) disease patients with necrotizing fasciitis. This finding improves understanding of GAS disease management.
Area of Science:
- Infectious Diseases
- Epidemiology
- Clinical Medicine
Background:
- Previous invasive Group A streptococcal (GAS) disease studies lacked sufficient sample size and generalizability.
- Invasive GAS disease remains a significant public health concern requiring further investigation.
Purpose of the Study:
- To describe clinical features of hospitalized invasive GAS disease patients.
- To identify risk factors associated with hospital mortality in invasive GAS disease.
Main Methods:
- Population-based study of 257 patients hospitalized with invasive GAS disease in Florida over 4 years.
- Logistic regression analysis was employed to determine adjusted odds ratios (OR) and 95% confidence intervals (CI) for mortality.
- Data collected from the Florida Department of Health provided comprehensive case information.
Main Results:
- Overall mortality for invasive GAS disease was 18% (41/228).
- Intensive care unit admission strongly predicted mortality (OR, 20.41; 95% CI, 6.41-64.96).
- Clindamycin treatment demonstrated a significant reduction in mortality for patients with necrotizing fasciitis (OR, 0.11; 95% CI, 0.01-0.89).
Conclusions:
- Clindamycin therapy is associated with reduced mortality in invasive GAS disease patients presenting with necrotizing fasciitis.
- Findings highlight the importance of specific antibiotic choices in managing severe GAS infections.
- Further research may explore optimal treatment strategies for invasive GAS disease based on clinical presentation.